Documentos de Valenzuela-Silva C.M. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área de conocimiento: "Farmacología"

Subtipo de publicación

Publisher

BMC Pharmacology and Toxicology(1)

Biopharmaceutics and Drug Disposition(1)

European Journal of Pharmaceutical Sciences(1)

Área temáticas

Farmacología y terapéutica(2)

Enfermedades(1)

Fisiología humana(1)

Área de conocimiento

Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar(3)

ODS 10: Reducción de las desigualdades(2)

ODS 9: Industria, innovación e infraestructura(2)

ODS 12: Producción y consumo responsables(1)

ODS 8: Trabajo decente y crecimiento económico(1)

Año de Publicación

Origen

Palabras Claves

2'-5' oligoadenylate synthetase(1)

Allometric scaling(1)

Beta2-microglobulin(1)

Dosage regimen(1)

Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody

Abstract: The multiple-dose strategy with the monoclonal ior EGF/r3 antibody, in xenograft bearing nude mice,

Palabras claves:

Allometric scaling, Dosage regimen, Integrated pharmacokinetic-pharmacodynamic, Monoclonal antibody ior EGF/r3, Survival time, Tumor growth delay

Alonso K., Alvarez D., Beausoleil I., Bécquer M.d.l.A., Castillo R., Duconge J., Fernández-Sánchez E.M., Matheu J., Tania Crombet, Valenzuela-Silva C.M., Vecino G.

Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers

Abstract: Background: More potent antitumor activity is desired in Interferon (IFN)-treated cancer patients. T

Palabras claves:

2'-5' oligoadenylate synthetase, Beta2-microglobulin, interferons, Neopterin, pharmacodynamics, pharmacokinetics

Bello-Rivero I., Campos-Mojena R., Cruz-Ramírez A., Díaz-Machado A., García-Vega Y., González-Delgado C.A., Hernández-González I., I. Howland-Álvarez, López-Saura P.A., Martín-Trujillo A., Pérez-Rodríguez S., Santana-Milián H., Tuero-Iglesias Á.D., Valenzuela-Silva C.M.

Topical disposition of two strengths of a <sup>125</sup>I-rhEGF jelly in rat skin wounds

Abstract: Growth factors have proved to be an effective therapeutic strategy. However, some controversies have

Palabras claves:

125 I-rhEGF, Jelly, Non-linearity, Strength, Topical disposition

Aguilera A., Alfonso-Ortíz S., Alvarez D., Bécquer M.d.l.A., Duconge J., Estrada L., Eugenio Hardy, Fernández-Sánchez E.M., García-Pulpeiro O., Prats P.A., Rojas I., Valenzuela-Silva C.M.